Children with hidradenitis suppurativa often receive antibiotics for about a year before switching to other therapies, a ...

Novartis’ IL-17 inhibitor Cosentyx has become the first new biological therapy for the painful skin condition hidradenitis suppurativa (HS) in nearly a decade, following its approval by the European ...

April 20, 2026 \. More for You ...

HKeybio Tech., a global leader in non-human primate (NHP) experimental animal model research and development, today announced the official launch of the world's first NHP Hidradenitis Suppurativa (HS) ...

Studies showing significant improvements in scalp hair coverage support the application for approval for adolescents and adults with severe alopecia areata.

Add a second biologic or JAK1 inhibitor to biologic monotherapyAvoid adding an IL-1 inhibitor, which could raise infection risk ...

AbbVie files for the FDA approval of Rinvoq in alopecia areata, backed by phase III data showing strong hair regrowth and ...

BOSTON and SUZHOU, China, April 21, 2026 /PRNewswire/ -- HKeybio Tech., a global leader in non-human primate (NHP) experimental animal model research and development, today announced the official ...

Insmed will discontinue a program evaluating brensocatib to treat a chronic inflammatory skin condition after a Phase 2b study failed to meet its primary or secondary endpoints. The biopharmaceutical ...

They were symptoms of hidradenitis suppurativa, a chronic inflammatory skin condition characterized by recurring abscesses, ...

European Commission approves Novartis Rhapsido for CSU in adult patients with inadequate response to H1-antihistamine treatment: Basel Tuesday, April 28, 2026, 09:00 Hrs [IST] Nov ...

The Skin of Color Society (SOCS), the world's leading professional society dedicated to advancing skin of color dermatology, successfully presented its 22nd Annual Scientific Symposium, "Championing ...